Muhammet Rıdvan Tayşi

ORCID: 0000-0002-2609-264X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Hepatitis Viruses Studies and Epidemiology
  • Infections and bacterial resistance
  • Bacterial Identification and Susceptibility Testing
  • Hepatitis C virus research
  • Diabetic Foot Ulcer Assessment and Management
  • Research on Leishmaniasis Studies
  • Dermatological diseases and infestations
  • Platelet Disorders and Treatments
  • Clinical Laboratory Practices and Quality Control
  • Urinary Tract Infections Management
  • Hepatitis B Virus Studies
  • Central Venous Catheters and Hemodialysis
  • Dermatological and COVID-19 studies
  • Antibiotics Pharmacokinetics and Efficacy
  • COVID-19 Clinical Research Studies
  • Virology and Viral Diseases
  • Antibiotic Use and Resistance
  • Immune responses and vaccinations
  • Streptococcal Infections and Treatments

Sağlık Bilimleri Üniversitesi
2022-2024

University of Health Science
2024

Konya Food and Agriculture University
2024

Selçuk University
2024

Dışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi
2022

Ministry of Health
2022

Abstract Objectives EUCAST published its recommendations for rapid antimicrobial susceptibility tests (RASTs) directly from positive signal blood culture (BC) bottles. The objective of the present study was to investigate accuracy and applicability predicted RAST (p-RAST) method without using automated identification systems, effects results obtained with this on treatment decision clinician. Methods procedure applied BC samples between November 2020 June 2021. categorical were by comparing...

10.1093/jac/dkac003 article EN Journal of Antimicrobial Chemotherapy 2022-01-11

With the rise in antimicrobial resistance, there is a growing demand for rapid susceptibility testing (RAST). In this study, we applied EUCAST RAST method to ESBL/carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolates without using advanced identification systems analysed effect of on mortality rates Also clinical impact patients infected with these bacteria its were investigated.

10.1093/jac/dkae125 article EN Journal of Antimicrobial Chemotherapy 2024-05-10

Stenotrophomonas maltophilia, a pathogen that colonizes medical equipment and causes nosocomial infections due to its ability form biofilms, has high mortality rates. This study investigated the risk factors related in patients who were diagnosed with S. maltophilia bacteremia. It is multi-center, retrospective ad observational cohort study. The demographic characteristics, clinical findings, microbiological data, for obtained from records of at ten different hospitals between January 1,...

10.1186/s12879-024-10293-4 article EN cc-by-nc-nd BMC Infectious Diseases 2024-12-05

Introduction: Leishmaniasis is a zoonosis caused by Leishmania spp. parasites through the bite of infected female sandflies and has three main forms: visceral (VL), cutaneous (CL) mucocutaneous (MCL). VL endemic in many countries around world. It on World Health Organisation's (WHO) list neglected diseases difficult to diagnose due its non-specific clinical manifestations. characterised fever, hepatosplenomegaly bone marrow suppression. The diagnosis made presence amastigotes tissue or blood...

10.54005/geneltip.1406185 article EN cc-by-nc Genel Tıp Dergisi 2024-06-14

Diabetes foot infection is a very important public health problem that causes serious problems, mortality, and high expenditures, one of the most complications diabetes mellitus. There are concerns approaches such as limited personal visits to doctors, avoidance hospitals, restrictions on nonemergency surgical procedures during coronavirus disease 2019 pandemic pose threat those with diabetic including ulcers (DFUs), ischemia, infection, resulting in increased limb loss mortality.

10.7547/22-073 article EN Journal of the American Podiatric Medical Association 2024-05-01

Objective: Coronaviruses and paramyxoviruses, both of which are RNA viruses, have similar structural glycoprotein characteristics. It is considered that antibodies developed against these structures may protect by cross-reaction because the glycoproteins viruses related to their ability infect cell.

10.29011/2575-789x.000182 article EN Journal of Vaccines Immunology and Immunopathology 2022-11-23
Coming Soon ...